glp 1 and bladder issues GLP-1 receptor agonists next-generation metabolic hormone therapies in chronic kidney disease GLP-1 and Gut Health: Addressing

GLP-1 RAs or a dual GIP and GLP-1 RA with demonstrated benefits are recommended for people with type 2 diabetes, obesity, and symptomatic HF with preserved ejection fraction (132135) ( Table 9.2 and Fig

All of our compounds include DAC which decreases the half life for a shorter, safer pulse

These actions seem to be responsible for i) the downregulation of inflammatory cytokines and ii) an overall shift from a pro-inflammatory (Th1/Th17) response to an anti-inflammatory/regulatory (Th2) response

Collectively, these convergent actions maintain genome integrity, preserve proteostasis, suppress inflammation, and attenuate cellular senescence, illustrating how GLP-1 RAs restore systemic homeostasis to promote healthy aging

*Note: Values marked with an asterisk exceed the capacity of a standard 1 mL (100-unit) insulin syringe